Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.53 |
| ▸ | GAA | P10253 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.47 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18639265 | 1.00 | KDM4E (0.53) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| SCHEMBL29594018 | 1.00 | KDM4E (0.53) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| SCHEMBL10480342 | 1.00 | KDM4E (0.53) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| SCHEMBL24198978 | 1.00 | KDM4E (0.53) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| SCHEMBL1485904 | 1.00 | KDM4E (0.53) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| SCHEMBL24514268 | 1.00 | KDM4E (0.53) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| SCHEMBL17822068 | 0.98 | KDM4E (0.52) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| Hydrochloric Acid SCHEMBL7002314 | 0.98 | KDM4E (0.52) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| SCHEMBL1425186 | 0.98 | KDM4E (0.52) | KDM4EGAAMAPTSMN1; SMN2RAB9A | |
| SCHEMBL17822021 | 0.96 | GAA (0.50) | KDM4EGAAMAPTSMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1832 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512830-B1 | METHOD FOR THE HYDROGENATION OF A MIXTURE IN THE PRESENCE OF A COLOURLESS AMINE | BASF SE (DE) | 2025-03-12 | — | — | EP | claimed |
| CN-119114095-A | Method for recycling industrial aniline waste liquid | 万华化学集团股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| EP-3995492-B1 | A TWO-STEP PROCESS FOR PREPARING 3-SUBSTITUTED PHENYLALKYLAMINES | SpecGx LLC (US) | 2024-05-29 | — | — | EP | claimed |
| CN-115322132-B | N-substituted indole compound and synthesis method thereof | 陕西科技大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117534570-A | Preparation method of dicyclohexylamine | 万华化学集团股份有限公司 | 2024-02-09 | — | — | CN | claimed |
| US-20240041795-A1 | Cyclic Ketone Compounds and Applications Thereof | WEST CHINA HOSPITAL, SICHUAN UNIVERSITY (CN) | 2024-02-08 | — | — | US | claimed |
| EP-4316493-A1 | NOVEL USE OF CYCLIC KETONE COMPOUND | West China Hospital, Sichuan University (CN) | 2024-02-07 | — | — | EP | claimed |
| CN-111253281-B | Preparation method of cyclohexanone oxime | 湘潭大学 | 2023-08-04 | — | — | CN | claimed |
| CN-116440811-A | Low-agent consumption process for preparing aniline by nitrobenzene liquid phase hydrogenation and application | 万华化学（宁波）有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-114917727-B | Hydrophobic eutectic solvent and preparation method and application thereof | 苏州中科地星创新技术研究所有限公司 | 2023-05-16 | — | — | CN | claimed |
| WO-1996027580-A1 | HYDROGENATION OF UNSATURATED CYCLIC COMPOUNDS | CHEMICAL RESEARCH & LICENSING COMPANY (US) | 1996-09-12 | — | — | WO | claimed |
| EP-0526793-B1 | Process for the preparation of diphenylamines | BAYER AG (DE) | 1995-06-28 | — | — | EP | claimed |
| EP-0526793-A2 | Process for the preparation of diphenylamines | BAYER AG (DE) | 1993-02-10 | — | — | EP | claimed |
| EP-0325132-B1 | RHODIUM CATALYSTS, PROCESS FOR THEIR PREPARATION AND PROCESS FOR THE PREPARATION OF OPTIONALLY SUBSTITUTED DIPHENYL AMINE USING THE RHODIUM CATALYSTS | BAYER AG (DE) | 1991-08-21 | — | — | EP | claimed |
| US-4975512-A | Crosslinking with amine, ammonium, hydrazine | PETROLEUM ENERGY CENTER (JP) | 1990-12-04 | — | — | US | claimed |
| EP-0325132-A1 | Rhodium catalysts, process for their preparation and process for the preparation of optionally substituted diphenyl amine using the rhodium catalysts | BAYER AG (DE) | 1989-07-26 | — | — | EP | claimed |
| US-4410730-A | Process for the production of o-(N-monosubstituted amino)benzyl alcohols | SHIONOGI & CO., LTD. (JP) | 1983-10-18 | — | — | US | claimed |
| US-4057581-A | CATALYTIC DEHYDROGENATION, NICKEL-CHROMIUM-MANGANESE OR COPPER OR ALUMINUM CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-08 | — | — | US | claimed |
| US-4042642-A | 1,3-BIS(MORPHOLINOTHIO)-IMIDAZOLIDINONE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-08-16 | — | — | US | claimed |
| US-3996505-A | Capacitor with liquid polybutene dielectric | MCGRAW-EDISON COMPANY (US) | 1976-12-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041795-A1 | Cyclic Ketone Compounds and Applications Thereof | BCKDK, PDK4, PKM | KDM4E 1022/4885GAA 3942/4885MAPT 2897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.